Sclareol Attenuates Liver Fibrosis Through SENP1-Mediated VEGFR2 SUMOylation and Inhibition of Downstream STAT3 Signaling

Researchers evaluated the anti-fibrotic activity of sclareol and explored its underlying mechanisms. Stimulated hepatic stellate cells served as an in vitro liver fibrosis model.